F. Dolz Sinisterra

Assessing the value contribution of bimekizumab for the treatment of moderate-to-severe psoriasis using a multidisciplinary reflective multi-criteria decision analysis

L. Puig, O. Delgado Sánchez, J. C. Carrascosa Carrillo, 2022, Expert review of pharmacoeconomics & outcomes research.

Unmet Needs in the Management of Moderate-to-Severe Psoriasis in Spain: A Multidimensional Evaluation

O. Delgado Sánchez, Á. Hidalgo-Vega, J. C. Carrascosa Carrillo, 2022, Acta dermato-venereologica.

The social value of a PASI 90 or PASI 100 response in patients with moderate-to-severe plaque psoriasis in Spain

O. Delgado Sánchez, Á. Hidalgo-Vega, M. Merino, 2023, Frontiers in Public Health.

Effectiveness and Safety of Methylprednisolone When Treating Patients with COVID-19 Pneumonia-Induced Severe Systemic Inflammation: A Retrospective, Cohort Study

R. Zaragoza Crespo, E. Martínez-Moragón, M. Climente-Martí, 2021, SSRN Electronic Journal.